Add to your list a repeal of the up to thirty year patent term for drugs. Reduce it to three years with no renewal. Next, allow drugs already approved in certain other first-world countries to be automatically legal here unless harm can be shown (i.e reverse the burden of proof).
Merck is currently spending $2.5 billion per year on clinical trials for Keytruda, one of the most promising treatments for cancer ever. Without the ability to recoup those costs drug development efforts would cease.
“Add to your list a repeal of the up to thirty year patent term for drugs. Reduce it to three years with no renewal. “
Is it really 3 decades now? Seems excessive.
But with just three years, drug companies may not recoup their expenses developing the drugs. So will not be putting in the effort to develop them. There has to be a financial incentive.